5q- Syndrome

Search Trials
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Active, not recruiting
Last Changed:
Oct 9, 2018
First Changed:
Oct 16, 2007
Disease(s):
Leukemia
Intervention(s):
fludarabine phosphatemelphalanallogeneic hematopoietic stem cell transplantationintensity-modulated radiation therapy
Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
Sep 27, 2018
First Changed:
May 3, 2013
Disease(s):
Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
Intervention(s):
DecitabineMidostaurin
Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
Status:
Terminated
Last Changed:
Jan 9, 2018
First Changed:
Mar 27, 2012
Disease(s):
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Intervention(s):
rasburicaseallopurinol
Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
Status:
Active, not recruiting
Last Changed:
Oct 4, 2018
First Changed:
Oct 8, 2007
Disease(s):
Adult Acute Myeloid Leukemia in Remission
Intervention(s):
busulfanetoposideintensity-modulated radiation therapyallogeneic hematopoietic stem cell transplantationallogeneic bone marrow transplantationperipheral blood stem cell transplantationtomotherapy
Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant
Status:
Terminated
Last Changed:
Feb 15, 2017
First Changed:
Jan 27, 2003
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
therapeutic allogeneic lymphocytesaldesleukinlaboratory biomarker analysisflow cytometry

Connect. Empower. Inspire.